However, the precise role of each HAS isoenzyme in breast cancer progression remains unknown; therefore, the identification of HAS1, -2, and -3 specific regulators should be a priority to avoid a general alteration of HA homeostasis. The gene discussed is HAS1; the disease is breast carcinoma.